Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProPhase Labs (PRPH) Non-Current Deferred Tax Liability: 2022

  • ProPhase Labs' Non-Current Deferred Tax Liability was N/A to $224,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $224,000, marking a year-over-year change of. This contributed to the annual value of $224,000 for FY2022, which is N/A change from last year.
  • ProPhase Labs' Non-Current Deferred Tax Liability amounted to $224,000 in Q4 2022, which was down 49.44% from $443,000 recorded in Q1 2022.
  • In the past 5 years, ProPhase Labs' Non-Current Deferred Tax Liability ranged from a high of $443,000 in Q1 2022 and a low of $224,000 during Q4 2022.
  • Over the past 1 years, ProPhase Labs' median Non-Current Deferred Tax Liability value was $333,500 (recorded in 2022), while the average stood at $333,500.